The evidence-based treatment group was more likely to have coexisting cardiovascular diseases, such as angina, myocardial infarction, atrial fibrillation, and valvular heart disease, and comorbidities, such as diabetes and hyperlipidemia.The non-use group was more likely to have been admitted to a primary or secondary hospital and treated by less specialized healthcare providers and was also more